Gestational hypertension/pre-eclampsia is the most frequent obstetrical complication, complicating 26%-29% of all gestations in nulliparous women. In general, the diagnosis of mild gestational hypertension/pre-eclampsia is made at 38 weeks or more in approximately 80% of cases. For many years, the optimal timing of delivery for patients with mild gestational hypertension/pre-eclampsia at 37-0/7 to 39-6/7 weeks was unclear. Recently, investigators of the HYPITAT (Pregnancy-induced hypertension and pre-eclampsia after 36 weeks: induction of labor versus expectant monitoring: A comparison of maternal and neonatal outcome, maternal quality of life and costs) randomized trial evaluated maternal and neonatal complications in patients at 36-40 weeks' gestation who were randomized to either induction of labor or expectant monitoring. The results of this trial revealed that induction of labor at or after 37-0 weeks was associated with lower rate of maternal complications without increased rates of either cesarean delivery or neonatal complications. In contrast, the optimum management for those with mild hypertension/pre-eclampsia with stable maternal and fetal conditions at 34-0/7 to 36-6/7 weeks remains uncertain. Therefore, there is urgent need for research to evaluate the reasons for late preterm birth in such women as well as for a randomized trial to evaluate the optimal timing for delivery in such patients. Semin Perinatol 35:292-296
G estational hypertension/pre-eclampsia is the most common obstetrical complication of pregnancy, with a reported incidence of approximately 10%. 1 Most cases of gestational hypertension/pre-eclampsia develop in healthy nulliparous women, with a reported incidence in this group of 26%-29%. 2, 3 The rate of gestational hypertension/pre-eclampsia is also increased in patients with one or more of the risk factors listed in Table 1 . 4 Gestational hypertension/pre-eclampsia is a syndrome that is characterized by heterogeneous clinical, radiologic, and laboratory findings. The clinical findings of pre-eclampsia can manifest as either a maternal syndrome (Fig. 1) or a fetal syndrome in the form of fetal growth restriction, oligohydramnios abruptio placentae, abnormal umbilical artery Doppler findings, and reduced placental weight with infarctions and abruptio placentae (Fig. 2) . 5 In some patients, particularly those with severe early onset pre-eclampsia, the clinical findings can affect both the mother and the fetus. 6 Gestational hypertension-pre-eclampsia can be associated with serious maternal and perinatal complications (both acute and long term). 4 The risk of these complication will depend on severity of the disease process, gestational age at onset, fetal and maternal conditions at time of diagnosis, and timing of delivery.
The primary objective of management in pregnancies complicated by gestational hypertension or pre-eclampsia must always be safety of the mother and the fetus, and then if possible, delivery of a mature newborn that will not require admission to a neonatal intensive care unit. This objective can be accomplished by formulating a management plan that considers one or more of the factors listed in Table 2 .
Because of the concern about maternal and fetal safety with continuation of pregnancy, delivery is recommended for all patients with severe gestational hypertension and severe preeclampsia at Ն34 weeks' gestation. 6 Therefore, women with these conditions will not be discussed further.
Mild Gestational Hypertension/ Pre-Eclampsia Occurring at or After 37 Weeks' Gestation
This group of women constitute most patients with hypertensive disorders of pregnancy. 7 For many years, the timing of delivery of such patients have been controversial. Some guidelines recommend all such patients undergo induction of labor at 37-38 weeks' gestation, whereas others recommend expectant monitoring until 40-0/7 weeks' gestation, onset of labor or rupture of membranes, or development of either a maternal or fetal indication for delivery. 8 All these guidelines were determined by expert opinion rather than randomized trials. Those who recommend delivery at 37-38 weeks' gestation cite maternal risks, such as progression to severe gestational hypertension or to pre-eclampsia eclampsia, abruptio placentae with expectant management. In contrast, those who recommend expectant monitoring site the increased rates of cesarean delivery from induction, particularly in those with unfavorable cervical Bishop score, as well as the increased rates of neonatal morbidities in infants born at 37-0/7 to 38-6/7 weeks' gestation.
The HYPITAT (Pregnancy-induced hypertension and preeclampsia after 36 weeks: induction of labor versus expectant monitoring. A comparison of maternal and neonatal outcome, maternal quality of life and costs.) trial was the first multicenter trial designed to compare the risks and benefits of induction of labor versus expectant monitoring for women with mild gestational hypertension/pre-eclampsia at Ն36-0/7 weeks' gestation. 9 The trial included 756 women with singleton pregnancy at 36-0/7 to 41-6/7 weeks who had mild gestational hypertension (n ϭ 496) or mild pre-eclampsia (n ϭ 246); 377 were allocated to induction and 379 to expectant monitoring. 9 The primary outcome was a composite (Table 3) . Secondary outcomes were a composite of adverse neonatal outcomes and the rate of cesarean delivery (Table 4) . Women randomized to the induction group had a significant reduction in primary outcome (Table 3 ). This reduction was mainly attributable to differences in the rates of progression to severe hypertension. There were no differences in adverse neonatal outcomes (Table 4). In addition, the overall rates of cesarean delivery were not different in both groups; however, in the induction group, the rate of cesarean delivery was lower in nulliparous women and in those with cervical Bishop score Ͻ2. This latter finding refutes the belief that induction of labor in these women increases the rate of cesarean delivery. Therefore, induction of labor and/or delivery at Ն37 weeks' gestation should be offered to all such women provided that gestational age is well documented and the induction period is not prolonged beyond 48 hours.
What Proportion of Late Preterm Deliveries Are Caused by Gestational Hypertension/Pre-Eclampsia?
Several retrospective studies reported the etiology of late preterm births in their population. [10] [11] [12] [13] The results of these studies are summarized in Table 5 . Gestational hypertension/preeclampsia was responsible for 10%-25% of late preterm deliveries. It is important to note that the indication for delivery in these studies was not clear because patients could have more than one indication for delivery. Also, the aforementioned findings were reported from academic medical centers and thus might not reflect the general practice in community hospitals. Thus, there is definite need for research to find out what proportion of late preterm delivery is attributable to gestational hypertension/pre-eclampsia in community hospitals.
What Is the Rate of Late Preterm Delivery in Women with Mild Gestational Hypertension/Pre-Eclampsia?
The exact rate of late preterm birth in gestational hypertension/pre-eclampsia in the United States is unknown. Three prospective cohort studies reported the aforementioned rates in healthy nulliparous women who later developed gestational hypertension/pre-eclampsia (Table 6) . 2, 14, 15 In women with mild gestational hypertension, the rate is Ͻ5%, whereas, in those with mild pre-eclampsia, the rate is approximately 10%. By contrast, the rate of late preterm delivery in patients with recurrent pre-eclampsia is 22.4%. 16 Again, these data were reported from academic centers.
Recently, Barton et al 17 reported on timing of delivery in 1251 women with stable mild gestational hypertension managed by community physicians. They found that 319 of the 1251 (25.5%) were delivered at 34-0/7 to 36-6/7 weeks' ges- tation. In addition, they found that "elective delivery" in women with mild and stable gestational hypertension was associated with increased rates of cesarean section. This latter finding was similar to that reported by Habli et al. 12 What Are the Neonatal Risks of Late Preterm Birth in Gestational Hypertension/Pre-Eclampsia?
Habli et al 12 reported neonatal outcomes in pregnancies with gestational hypertension/pre-eclampsia as compared with those in normotensive pregnancies that delivered at 35-0 to 35-6/7 or 36-0 to 36-6/7 weeks' gestation. Compared with normotensive pregnancies, infants born to hypertensive women delivered at either 35 or 36 weeks had greater rates of admission to neonatal intensive care unit (57.1% vs 34.5% at 35 weeks) and 33.3% vs 10.7% at 36 weeks. In addition, infants born to hypertensive women at 36-0 to 36-6/7 weeks of gestation had greater mean total days of neonatal hospitalization (5.5 Ϯ 4.8 vs 2.8 Ϯ 4.2), and greater rates of respiratory distress syndrome (9.5% vs 1.6%). 12 The reasons for these differences may be related to the greater rates of smallfor-gestational age and greater rates of induction of labor among the hypertensive group. Barton et al 17 also reported neonatal complications by week of gestation at time of late preterm delivery in patients with mild gestational hypertension. The authors found high rates of small for gestational age (22.3%) and high rate of admission to the neonatal intensive care unit (27.3%) among these infants. In addition, they found that neonatal complications were reduced progressively from 34 to 36 weeks' gestation (Fig. 3 ).
Summary and Recommendations
There is evidence-based data from the HIPITAT trial that suggests that delivery is indicated in pregnancies complicated by mild gestational hypertension or mild pre-eclampsia occurring at 37 or more weeks' gestation. By contrast, there are no data to support that expectant monitoring in women with mild gestational hypertension/pre-eclampsia at 34-0 to 36-6/7 weeks will improve perinatal outcomes and/or increase maternal and fetal risks. The potential risks from expectant monitoring in such pregnancies are summarized in Table 7 . In the absence of randomized trials, there is expert opinion recommendations for expectant monitoring in these women in the absence of any of the factors listed in Table 8 .
Currently, there are no data describing the exact reasons for late preterm delivery in women with mild hypertension or mild pre-eclampsia. Such data are not available for nulliparous women and for women with preexisting risk factors, such as obesity, previous history of adverse pregnancy outcome, chronic hypertension, or renal disease. It is usually assumed that these patients are delivered secondary to hypertension or pre-eclampsia because of medicolegal concerns by the obstetrical providers. Thus, there is definite need to conduct research in this area. In addition, there is an urgent need for a randomized trial to determine the optimal timing of delivery in women with mild gestational hypertension, or pre-eclampsia at 34-0/7 to 36-6/7 weeks' gestation.
